.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
AstraZeneca
Cerilliant
Medtronic
Accenture
Harvard Business School
Julphar
Queensland Health
McKesson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: auranofin

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sebela Ireland LtdRIDAURAauranofinCAPSULE;ORAL018689NDASebela Pharmaceuticals Inc.N54766-093-06
Sebela Ireland LtdRIDAURAauranofinCAPSULE;ORAL018689NDAPrometheus Laboratories Inc.E65483-093-06
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Deloitte
Colorcon
Mallinckrodt
US Department of Justice
Boehringer Ingelheim
Citi
Farmers Insurance
Chubb

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot